10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 314 filers reported holding 10X GENOMICS INC in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $218,447 | -10.5% | 3,912 | -10.5% | 0.00% | -25.0% |
| Q1 2023 | $243,972 | -53.6% | 4,373 | -53.5% | 0.00% | 0.0% |
| Q4 2022 | $525,518 | +82.5% | 9,412 | +387.4% | 0.00% | -42.9% |
| Q4 2021 | $288,000 | +9.1% | 1,931 | +6.2% | 0.01% | -12.5% |
| Q3 2021 | $264,000 | +16.8% | 1,818 | +57.4% | 0.01% | +14.3% |
| Q2 2021 | $226,000 | +2160.0% | 1,155 | +1550.0% | 0.01% | – |
| Q4 2020 | $10,000 | -41.2% | 70 | -50.0% | 0.00% | -100.0% |
| Q3 2020 | $17,000 | – | 140 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |